Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells (Q40319699)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 February 2006

edit

Language	Label	Description	Also known as
English	Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells	scientific article published on 4 February 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

title

Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

main subject

uterine sarcoma

1 reference

based on heuristic

inferred from title

author name string

Lars Petter Jordheim

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

Carlos M Galmarini

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

Charles Dumontet

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

publication date

4 February 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

published in

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

volume

58

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

page(s)

547-554

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

cites work

Newer approaches to gemcitabine-based therapy of pancreatic cancer: fixed-dose-rate infusion and novel agents

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00280-006-0195-8

retrieved

21 January 2018

Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00280-006-0195-8

retrieved

21 January 2018

International Commission for Protection Against Environmental Mutagens and Carcinogens. Deoxyribonucleoside triphosphate levels: a critical factor in the maintenance of genetic stability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00280-006-0195-8

retrieved

21 January 2018

Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00280-006-0195-8

retrieved

21 January 2018

Identifiers

DOI

10.1007/S00280-006-0195-8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

Dimensions Publication ID

1017443530

0 references

PubMed publication ID

16463058

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16463058

retrieved

19 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40319699&oldid=2203599761"